NCT00648960View on ClinicalTrials.gov

Comparative Bioavailability Study of Clarithromycin 500 mg Tablets in Fasting State

PHASE1CompletedINTERVENTIONAL

Enrollment

64

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

July 31, 2003

Study Completion Date

July 31, 2003

Conditions

Healthy

Interventions

DRUG

Clarithromycin

Single-dose 500 mg immediate-release oral tablet

DRUG

Clarithromycin

Single-dose 500 mg immediate-release oral dose

Trial Locations (1)

H7V 4B4

Algorithme Pharma, Laval

Sponsors

Lead Sponsor

Mylan Pharmaceuticals Inc

Collaborators (1)

All Listed Sponsors

collaborator

Genpharm ULC

INDUSTRY

lead

Mylan Pharmaceuticals Inc

INDUSTRY